PWA
HALO icon

Provenance Wealth Advisors’s Halozyme HALO Stock Holding History

Provenance Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25
Closed -$1.59K – 477
2025
Q1 		$1.59K Hold
25
– – ﹤0.01% 420
2024
Q4 		$1.2K Hold
25
– – ﹤0.01% 478
2024
Q3 		$1.43K Hold
25
– – ﹤0.01% 498
2024
Q2 		$1.31K Hold
25
– – ﹤0.01% 417
2024
Q1 		$1.02K Hold
25
– – ﹤0.01% 480
2023
Q4 		$924 Buy
25
+1
+4% +$38 ﹤0.01% 534
2023
Q3 		$917 Buy
+24
New +$983 ﹤0.01% 413

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Provenance Wealth Advisors's HALO Position: Q2 2025 in Review

Provenance Wealth Advisors sold out of Halozyme (HALO) in Q2 2025, closing a stake of 25 shares — an estimated $1.59K sold.

Provenance Wealth Advisors first reported a position in HALO in Q3 2023 and held it in 7 quarters. The position peaked at $1.59K in Q1 2025. 551 funds tracked by Wall St. Rank hold HALO as of Q2 2025.

  • Provenance Wealth Advisors reported no remaining Halozyme position as of Q2 2025 after selling out during the quarter.
  • Provenance Wealth Advisors sold 25 Halozyme shares in Q2 2025, an estimated $1.59K.
  • Provenance Wealth Advisors first reported a position in Halozyme in Q3 2023 and held it in 7 quarters.
  • Provenance Wealth Advisors's Halozyme position peaked at $1.59K in Q1 2025.
  • 551 funds tracked by Wall St. Rank held Halozyme as of Q2 2025.

Based on Provenance Wealth Advisors's 13F filing for Q2 2025, filed 15 Aug 2025.